About Enantigen
Enantigen Therapeutics, Inc., located at the Pennsylvania Biotechnology Center, is an innovative pharmaceutical company striving for excellence in the discovery, development and commercialization of novel drugs to treat life threatening infectious diseases. The primary focus is on the development of oral therapeutics for the treatment of Hepatitis B, Hepatitis C, Hepatocellular Carcinoma (HCC), and other viral related diseases.